DIPYRIDAMOLE - A CRITICAL-EVALUATION

被引：28

作者：

RIVEY, MP

ALEXANDER, MR

TAYLOR, JW

机构：

[1] UNIV IOWA, COLL PHARM, IOWA CITY, IA 52242 USA

[2] UNIV MONTANA, SCH PHARM, MISSOULA, MT 59812 USA

[3] UNIV MICHIGAN HOSP, ANN ARBOR, MI 48109 USA

[4] UNIV MICHIGAN, COLL PHARM, ANN ARBOR, MI 48109 USA

来源：

DRUG INTELLIGENCE & CLINICAL PHARMACY | 1984年 / 18卷 / 11期

关键词：

D O I：

10.1177/106002808401801103

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：869 / 880

页数：12

共 167 条

[1]

ABRAHAMSEN AF, 1974, SCAND J HAEMATOL, V13, P241

[2] CONTROLLED TRIAL OF DIPYRIDAMOLE IN CEREBRAL VASCULAR DISEASE [J].

ACHESON, J ;

DANTA, G ;

HUTCHINSON, EC .

BMJ-BRITISH MEDICAL JOURNAL, 1969, 1 (5644) :614-+

[3]

ADOLFSSON J, 1982, ACTA PATH MICRO IM A, V90, P273

[4] DIPYRIDAMOLE - POSSIBLE POTENT INHIBITOR OF THROMBOXANE A2 SYNTHETASE IN VASCULAR SMOOTH-MUSCLE [J].

ALLY, AI ;

MANKU, MS ;

HORROBIN, DF ;

MORGAN, RO ;

KARMAZIN, M ;

KARMALI, RA .

PROSTAGLANDINS, 1977, 14 (03) :607-609

[5]

ANDERSON M, 1974, CLIN NEPHROL, V2, P93

[6]

[Anonymous], 1980, CIRCULATION, V62, P449

[7]

Arrants J E, 1972, Am Surg, V38, P432

[8]

BAKER RN, 1968, NEUROLOGY, V18, P11

[9]

BARCIAMARINO C, 1970, MED CLIN-BARCELONA, V55, P195

[10]

BARNETT HJM, 1976, CEREBROVASC DIS, V10, P1

← 1 2 3 4 5 6 7 8 9 10 →